Market Currents
Array BioPharma (ARRY) up 25.8% AH as it signs a deal worth up to $467M ($45M up front and $422M...
-
Monday, April 19, 2010, 5:31 PM ETArray BioPharma (ARRY) up 25.8% AH as it signs a deal worth up to $467M ($45M up front and $422M in milestones) with Novartis (NVS) to license its experimental cancer drug candidates.
Other date
Latest Articles
